tiprankstipranks
UCB SA (UCBJF)
OTHER OTC:UCBJF

Compare UCB SA (UCBJF) vs. Competitors

72 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
UCB SA
$326.39
$59.34B
29.10
104.76%
6 Buy
2 Hold
0 Sell
Strong Buy
UCB SA
€266.76
€50.88B
29.10
80.82%
6 Buy
2 Hold
0 Sell
Strong Buy
AstraZeneca
15216.00 p
£235.97B
28.13
46.67%
13 Buy
2 Hold
1 Sell
Strong Buy
GlaxoSmithKline
2125.00 p
£84.92B
12.93
58.52%
3 Buy
6 Hold
3 Sell
Hold
Hikma Pharmaceuticals
1554.00 p
£2.84B
11.21
-28.63%
2 Buy
0 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
UCBJF
UCB SA
326.39
176.70
118.04%
GB:0NZT
UCB SA
266.77
127.95
92.18%
GB:AZN
AstraZeneca
15,216.00
5,369.61
54.53%
GB:GSK
GlaxoSmithKline
2,125.00
899.78
73.44%
GB:HIK
Hikma Pharmaceuticals
1,314.00
-447.36
-25.40%
GB:INDV
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts